Recent events
Recent events tied to this brand in public sources.
Back to profile3 entries
2021
BiondVax prices $9 million public offering
BiondVax announced pricing an underwritten public offering of 3,813,560 American Depositary Shares at $2.36 per share, for gross proceeds of approximately $9.0 million before expenses. The offering was expected to close on or about December 29, subject to customary conditions.
2021
Amir Reichman begins serving as BiondVax CEO
Amir Reichman began serving as BiondVax's CEO, according to the company's business highlights.
2020
BiondVax announces 2019 financial results
BiondVax Pharmaceuticals announced its fourth-quarter and full-year 2019 financial results and provided a business update.